GET 20% OFF ON YOUR FIRST ORDER + FREE SHIPPING USE CODE FIRSTORDER20
CBD – FDA think about CBD and children’s epilepsy
October 17, 2019
The FDA has approved Epidiolex, which contains a purified form of the drug substance CBD, for the treatment of seizures associated with Lennox-Gastaut syndrome or Dravet syndrome in patients 2 years of age and older. That means the FDA has concluded that this particular drug product is safe and effective for its intended use. Controlled clinical trials testing the safety and efficacy of a drug, along with careful review through the FDA’s drug approval process, is the most appropriate way to bring cannabis-derived treatments to patients. Because of the adequate and well-controlled clinical studies that supported this approval, and the assurance of manufacturing quality standards, prescribers can have confidence in the drug’s uniform strength and consistent delivery that support appropriate dosing needed for treating patients with these complex and serious epilepsy syndromes.
share:
  • FOLLOW US ON INSTAGRAM

    @cbd_colors
    BACK TO TOP

    Someone purchased a

    Product name

    info info